2025 North America Blood Group Typing Market Revenue Opportunities Report
Description
The 2025 North America Blood Group Typing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Group Typing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North America Blood Group Typing Market are Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., and Ortho Clinical Diagnostics, Inc. Bio-Rad Laboratories is a dominant U.S.-based player known for innovations such as the IH-500 System and ID-MTS Gel Cards, and recently expanded capabilities with acquisitions like Stilla Technologies to enhance digital PCR applications. Grifols, headquartered in Spain, holds a significant market presence through its broad product portfolio in diagnostics and blood typing solutions. Immucor, a U.S. company now unified under Werfen, specializes in transfusion diagnostics and has a strong footprint in North America. Ortho Clinical Diagnostics also holds a leadership role with an extensive range of blood typing instruments and assays used widely in hospitals and blood banks.
These companies benefit from advanced research and development, robust healthcare infrastructures in North America, and growing demand driven by increased blood transfusions, chronic disease prevalence, and surgical procedures. The U.S. dominates with a large share due to high voluntary blood donations and regulatory support. Trends among these firms include automation, molecular typing enhancements, and integration of AI-powered analyzers to improve speed and accuracy in blood group typing. Their extensive distribution networks and innovation in assay-based and molecular blood typing maintain their leading positions, fueling North America's largest share in the global market.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Group Typing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North America Blood Group Typing Market are Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., and Ortho Clinical Diagnostics, Inc. Bio-Rad Laboratories is a dominant U.S.-based player known for innovations such as the IH-500 System and ID-MTS Gel Cards, and recently expanded capabilities with acquisitions like Stilla Technologies to enhance digital PCR applications. Grifols, headquartered in Spain, holds a significant market presence through its broad product portfolio in diagnostics and blood typing solutions. Immucor, a U.S. company now unified under Werfen, specializes in transfusion diagnostics and has a strong footprint in North America. Ortho Clinical Diagnostics also holds a leadership role with an extensive range of blood typing instruments and assays used widely in hospitals and blood banks.
These companies benefit from advanced research and development, robust healthcare infrastructures in North America, and growing demand driven by increased blood transfusions, chronic disease prevalence, and surgical procedures. The U.S. dominates with a large share due to high voluntary blood donations and regulatory support. Trends among these firms include automation, molecular typing enhancements, and integration of AI-powered analyzers to improve speed and accuracy in blood group typing. Their extensive distribution networks and innovation in assay-based and molecular blood typing maintain their leading positions, fueling North America's largest share in the global market.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
